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Background
Use of biologics in rheumatological patients can provoke
psoriasis «de novo». It is well known phenomenon for
TNF-ingibitors. We reported a serious incident of psor-
iasis-like skin lesions caused by rituximab use in a child
with systemic lupus erythematosus (SLE).
Case report
We have observed a 14-years-old female patient suffer-
ing from SLE during 4 years. She has, severe progressive
nephritis with nephrotic syndrome (proteinuria 4 g/24
h), hematuria, hypoalbuminemia, high positive autoim-
munity tests (ANA, anti DNA), IV class of lupus-nephri-
tis by kidney biopsy. In the first year of disease the
treatment of pulse therapy with methylprednisolone
(MP) and cyclophosphamide was effective and resulted
in remission of the disease. Relapse was developed after
4 years. MP Pulse therapy (6 procedures) was not suc-
cessful. Rituximab therapy 375 mg/m
2 (500 mg) was
started. 2 days later the first infusion widespread papular
rash without itching was appeared and persisting for 2
weeks. Then we observed febrile fever, widespread poly-
morphic rash (macular, papular, pustular, bullous), ESR
90 mm/hour, CRP 60 mg/l, proteinuria 3.7-4.1 g/24.
Procalcitonin test was negative. Plating of pustules
secretions was sterile. Skin biopsy revealed the phenom-
enon of hyperkeratosis, exfoliation of superficial layers
of epidermis. Antibiotic and antihistamine therapy were
ineffective. It was increased the dose of methylpredniso-
lone to 1.3 mg/kg, cyclosporine A and topical skin ster-
oids were added. Rituximab was canceled. The
treatment was result in positive effects: reduction of
proteinuria, hematuria and cutaneous manifestations.
Conclusions
Rituximab therapy in autoimmune diseases may induce
unusual psoriasis-like reactions.
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